Century Therapeutics (IPSC) Interest & Investment Income (2022 - 2026)

Century Therapeutics (IPSC) has 5 years of Interest & Investment Income data on file, last reported at $2.0 million in Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.0 million, down 16.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (down 43.04% YoY), and the FY2025 annual result was $7.3 million, down 43.52% from the prior year.
• Interest & Investment Income advanced to $2.0 million in Q1 2026 per IPSC's latest filing, from $1.3 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $3.6 million in Q2 2024 and troughed at $706000.0 in Q2 2022.
• A 5-year average of $2.5 million and a median of $2.6 million in 2023 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 333.14% in 2023, then tumbled 54.56% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $1.4 million in 2022, then surged by 148.76% to $3.5 million in 2023, then dropped by 17.92% to $2.9 million in 2024, then plunged by 54.56% to $1.3 million in 2025, then surged by 54.24% to $2.0 million in 2026.
• Business Quant data shows IPSC's Interest & Investment Income at $2.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.